Author： Smith Paul F
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 443-456
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Role of Cannabinoids in Multiple Sclerosis
CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. :
Access to resources
Recommend
The use of cannabinoids in multiple sclerosis
Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. :
Prescribing Cannabinoids for Multiple Sclerosis: Current Issues
By Pertwee R.G.
CNS Drugs, Vol. 11, Iss. 5, 1999-05 ,pp. :
Multiple sclerosis and its treatment
By Giovannoni Gavin Miller David H
Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. :
Multiple Sclerosis: Pathogenesis and Treatment
Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. :